Published in Aliment Pharmacol Ther on March 04, 2010
Therapeutic efficacy of baclofen in refractory gastroesophageal reflux-induced chronic cough. World J Gastroenterol (2013) 0.91
A Gut Feeling about GABA: Focus on GABA(B) Receptors. Front Pharmacol (2010) 0.89
Validation of the reflux symptom questionnaire electronic diary in partial responders to proton pump inhibitor therapy. Clin Transl Gastroenterol (2012) 0.86
Current pharmacological management of gastroesophageal reflux disease. Gastroenterol Res Pract (2013) 0.80
Pharmacokinetic profile of lesogaberan (AZD3355) in healthy subjects: a novel GABA(B)-receptor agonist reflux inhibitor. Drugs R D (2011) 0.78
What is nonacid reflux disease? Can J Gastroenterol (2011) 0.77
Evaluation of peripheral versus central effects of GABA(B) receptor activation using a novel, positive allosteric modulator of the GABA(B) receptor ADX71943, a pharmacological tool compound with a fully peripheral activity profile. Br J Pharmacol (2014) 0.76
Different in vitro and in vivo profiles of substituted 3-aminopropylphosphinate and 3-aminopropyl(methyl)phosphinate GABA(B) receptor agonists as inhibitors of transient lower oesophageal sphincter relaxation. Br J Pharmacol (2012) 0.76
Acid infusion into the esophagus increases the number of meal-induced transient lower esophageal sphincter relaxations (TLESRs) in healthy volunteers. Neurogastroenterol Motil (2014) 0.76
Evaluation of the pharmacokinetic interaction between lesogaberan (AZD3355) and esomeprazole in healthy subjects. Drugs R D (2010) 0.75
Reflux disease as a motility disorder: treatment alternatives to acid suppression. Gastroenterology (2010) 0.75
Dose-dependent effects of lesogaberan on reflux measures in patients with refractory gastroesophageal reflux disease: a randomized, placebo-controlled study. BMC Gastroenterol (2014) 0.75
A method for measuring chemotaxis and use of the method to determine optimum conditions for chemotaxis by Escherichia coli. J Gen Microbiol (1973) 18.10
Nonchemotactic mutants of Escherichia coli. J Bacteriol (1967) 13.70
Chemotaxis in bacteria. Science (1966) 13.45
Chemoreceptors in bacteria. Science (1969) 12.30
Change in direction of flagellar rotation is the basis of the chemotactic response in Escherichia coli. Nature (1974) 8.95
Chemotaxis toward amino acids in Escherichia coli. J Bacteriol (1972) 7.75
Role of the galactose binding protein in chemotaxis of Escherichia coli toward galactose. Nat New Biol (1971) 7.53
Chemotaxis in bacteria. Annu Rev Biochem (1975) 7.48
The effect of environmental conditions on the motility of Escherichia coli. J Gen Microbiol (1967) 6.92
The range of attractant concentrations for bacterial chemotaxis and the threshold and size of response over this range. Weber law and related phenomena. J Gen Physiol (1973) 6.92
Attachment of flagellar basal bodies to the cell envelope: specific attachment to the outer, lipopolysaccharide membrane and the cyoplasmic membrane. J Bacteriol (1971) 6.91
Protein methylation in behavioural control mechanisms and in signal transduction. Nature (1979) 6.87
Sensory transduction in Escherichia coli: two complementary pathways of information processing that involve methylated proteins. Proc Natl Acad Sci U S A (1977) 6.63
Negative chemotaxis in Escherichia coli. J Bacteriol (1974) 6.49
Methylation of a membrane protein involved in bacterial chemotaxis. Proc Natl Acad Sci U S A (1975) 6.14
Fine structure and isolation of the hook-basal body complex of flagella from Escherichia coli and Bacillus subtilis. J Bacteriol (1971) 6.00
Chemomechanical coupling without ATP: the source of energy for motility and chemotaxis in bacteria. Proc Natl Acad Sci U S A (1974) 5.64
Purification of intact flagella from Escherichia coli and Bacillus subtilis. J Bacteriol (1971) 5.29
Genetics of motility in Escherichia coli: complementation of paralysed mutants. Genetics (1967) 5.14
Chemotaxis toward sugars in Escherichia coli. J Bacteriol (1973) 5.10
Complementation of nonchemotactic mutants of Escherichia coli. Genetics (1969) 5.06
Pressure-sensitive ion channel in Escherichia coli. Proc Natl Acad Sci U S A (1987) 5.06
ENZYMATIC SYNTHESIS OF DEOXYRIBONUCLEIC ACID. III. THE INCORPORATION OF PYRIMIDINE AND PURINE ANALOGUES INTO DEOXYRIBONUCLEIC ACID. Proc Natl Acad Sci U S A (1958) 4.99
A method for measuring the motility of bacteria and for comparing random and non-random motility. J Gen Microbiol (1967) 4.37
Escherichia coli mutants defective in chemotaxis toward specific chemicals. Proc Natl Acad Sci U S A (1969) 4.33
Change in intracellular pH of Escherichia coli mediates the chemotactic response to certain attractants and repellents. J Bacteriol (1981) 4.16
Location of genes for motility and chemotaxis on the Escherichia coli genetic map. J Bacteriol (1969) 3.94
Sensory transduction in Escherichia coli: role of a protein methylation reaction in sensory adaptation. Proc Natl Acad Sci U S A (1977) 3.93
Identification of a methyl-accepting chemotaxis protein for the ribose and galactose chemoreceptors of Escherichia coli. Proc Natl Acad Sci U S A (1979) 3.65
Mechanosensitive ion channels of E. coli activated by amphipaths. Nature (1990) 3.55
Effect of amino acids and oxygen on chemotaxis in Escherichia coli. J Bacteriol (1966) 3.50
In vivo visualization of myelin water in brain by magnetic resonance. Magn Reson Med (1994) 3.25
Phosphotransferase-system enzymes as chemoreceptors for certain sugars in Escherichia coli chemotaxis. Proc Natl Acad Sci U S A (1974) 2.92
Failure of sensory adaptation in bacterial mutants that are defective in a protein methylation reaction. Cell (1978) 2.81
Meta-analysis: rapid infliximab infusions are safe. Aliment Pharmacol Ther (2013) 2.76
Properties of mutants in galactose taxis and transport. J Bacteriol (1974) 2.61
Genetic and biochemical properties of Escherichia coli mutants with defects in serine chemotaxis. J Bacteriol (1980) 2.55
Isolation and complementation of mutants in galactose taxis and transport. J Bacteriol (1974) 2.49
Isolation of glutamic acid methyl ester from an Escherichia coli membrane protein involved in chemotaxis. J Biol Chem (1977) 2.39
DnaK, DnaJ, and GrpE are required for flagellum synthesis in Escherichia coli. J Bacteriol (1992) 2.28
How bacteriophage chi attacks motile bacteria. J Virol (1967) 2.28
Change in membrane potential during bacterial chemotaxis. Proc Natl Acad Sci U S A (1976) 2.27
Modified reconstitution method used in patch-clamp studies of Escherichia coli ion channels. Biophys J (1989) 2.25
"Decision"-making in bacteria: chemotactic response of Escherichia coli to conflicting stimuli. Science (1974) 2.24
ENZYMATIC SYNTHESIS OF DEOXYRIBONUCLEIC ACID. V. CHEMICAL COMPOSITION OF ENZYMATICALLY SYNTHESIZED DEOXYRIBONUCLEIC ACID. Proc Natl Acad Sci U S A (1958) 2.18
Role of methionine in bacterial chemotaxis: requirement for tumbling and involvement in information processing. Proc Natl Acad Sci U S A (1975) 2.16
Long-term results of a prospective randomized comparison of total fundic wrap (Nissen-Rossetti) or semifundoplication (Toupet) for gastro-oesophageal reflux. Br J Surg (1996) 2.11
Pleiotropic aspartate taxis and serine taxis mutants of Escherichia coli. J Gen Microbiol (1979) 2.08
Attractants and repellents control demethylation of methylated chemotaxis proteins in Escherichia coli. Proc Natl Acad Sci U S A (1979) 1.99
Use of a computer to assay motility in bacteria. Anal Biochem (1988) 1.94
Sensory transduction in Escherichia coli: a requirement for methionine in sensory adaptation. Proc Natl Acad Sci U S A (1977) 1.92
Mechanism of adverse conditions causing lack of flagella in Escherichia coli. J Bacteriol (1993) 1.87
Chemotactic response of Escherichia coli to chemically synthesized amino acids. J Bacteriol (1983) 1.79
Adverse conditions which cause lack of flagella in Escherichia coli. J Bacteriol (1993) 1.76
Attraction by repellents: an error in sensory information processing by bacterial mutants. Science (1978) 1.73
Methanol formation in vivo from methylated chemotaxis proteins in Escherichia coli. J Biol Chem (1979) 1.67
Geranylgeraniol - a new potential therapeutic approach to bisphosphonate associated osteonecrosis of the jaw. Oral Oncol (2011) 1.53
Characterization of mechanosensitive channels in Escherichia coli cytoplasmic membrane by whole-cell patch clamp recording. J Membr Biol (1995) 1.53
Virus-like particles from killer, neutral, and sensitive strains of Saccharomyces cerevisiae. J Virol (1976) 1.52
Evolutionary conservation of methyl-accepting chemotaxis protein location in Bacteria and Archaea. J Bacteriol (2000) 1.50
Primary blast injury after a bomb explosion in a civilian bus. Ann Surg (1989) 1.46
Motility and chemotaxis of filamentous cells of Escherichia coli. J Bacteriol (2000) 1.45
The behaviour of the cervix uteri in vivo. J Physiol (1944) 1.43
Fusion of bacterial spheroplasts by electric fields. Biochim Biophys Acta (1985) 1.43
Effect of outer membrane permeability on chemotaxis in Escherichia coli. J Bacteriol (1990) 1.39
Norepinephrine and N(G)-monomethyl-L-arginine in hyperdynamic septic shock in pigs: effects on intestinal oxygen exchange and energy balance. Crit Care Med (2000) 1.38
Bacterial cell envelopes with functional flagella. J Biol Chem (1981) 1.30
Involvement of cyclic GMP in intracellular signaling in the chemotactic response of Escherichia coli. Proc Natl Acad Sci U S A (1980) 1.29
Purification and chemistry of bacteriophage chi. J Virol (1967) 1.27
Pneumatic dilatation or laparoscopic cardiomyotomy in the management of newly diagnosed idiopathic achalasia. Results of a randomized controlled trial. World J Surg (2007) 1.26
Effect of mutation of potassium-efflux system, KefA, on mechanosensitive channels in the cytoplasmic membrane of Escherichia coli. J Membr Biol (1996) 1.21
A novel mechanism of resistance to penicillin-gentamicin synergism in Streptococcus faecalis. J Infect Dis (1980) 1.21
Calcium ions are involved in Escherichia coli chemotaxis. Proc Natl Acad Sci U S A (1992) 1.18
Stent insertion or endoluminal brachytherapy as palliation of patients with advanced cancer of the esophagus and gastroesophageal junction. Results of a randomized, controlled clinical trial. Dis Esophagus (2005) 1.18
Sarcoidosis of the stomach and rectum. Am J Gastroenterol (1980) 1.17
Attractants and repellents influence methylation and demethylation of methyl-accepting chemotaxis proteins in an extract of Escherichia coli. Proc Natl Acad Sci U S A (1979) 1.16
Removal of glycosaminoglycans from cultures of human skin fibroblasts. Biochem J (1981) 1.14
Osmotaxis in Escherichia coli. Proc Natl Acad Sci U S A (1988) 1.13
Inhibition of Escherichia coli chemotaxis by omega-conotoxin, a calcium ion channel blocker. J Bacteriol (1993) 1.13
Does massive obesity promote abnormal gastroesophageal reflux? Dig Dis Sci (1995) 1.13
Effects of organic antagonists of Ca(2+), Na(+), and K(+) on chemotaxis and motility of escherichia coli. J Bacteriol (2000) 1.12
Arthritis: what it is, why you get it and how to stop the pain. Newsweek (2001) 1.08
Adenylate cyclase is required for chemotaxis to phosphotransferase system sugars by Escherichia coli. J Bacteriol (1983) 1.07
Epi-fluorescence microscopy and image analysis used to measure diffusion coefficients in gel systems. J Pharm Pharmacol (1992) 1.06
Chemotaxis in bacteria. J Supramol Struct (1976) 1.05
The sensing of chemicals by bacteria. Sci Am (1976) 1.05
Phototaxis away from blue light by an Escherichia coli mutant accumulating protoporphyrin IX. Proc Natl Acad Sci U S A (1995) 1.04
The Hippo pathway kinase Lats2 prevents DNA damage-induced apoptosis through inhibition of the tyrosine kinase c-Abl. Cell Death Differ (2013) 1.04
Studies on avian erythrocyte metabolism. Inositol tetrakisphosphate: the major phosphate compound in the erythrocytes of the ostrich (Struthio camelus camelus). Eur J Biochem (1977) 1.04
Membrane-derived oligosaccharides (MDO's) promote closing of an E. coli porin channel. FEBS Lett (1992) 1.04
Ion channels in Paramecium, yeast and Escherichia coli. Trends Biochem Sci (1988) 1.03
Ion channel activities in the Escherichia coli outer membrane. Biochim Biophys Acta (1990) 1.02
Cytoplasmic free-Ca2+ level rises with repellents and falls with attractants in Escherichia coli chemotaxis. Proc Natl Acad Sci U S A (1995) 1.02
Chemotaxis in Escherichia coli. Cold Spring Harb Symp Quant Biol (1965) 1.02
Bacterial flora of the human oral cavity, and the upper and lower esophagus. Dis Esophagus (2012) 1.02
Terrorist bombing experience during 1975-79. Casualties admitted to the Shaare Zedek Medical Center. Isr J Med Sci (1983) 1.01
Patch clamp studies of microbial ion channels. Methods Enzymol (1992) 1.00
The effect of baclofen on gastro-oesophageal reflux, lower oesophageal sphincter function and reflux symptoms in patients with reflux disease. Aliment Pharmacol Ther (2002) 0.99
Tailoring antireflux surgery: A randomized clinical trial. World J Surg (1999) 0.98
Mechanism of action of antireflux procedures. Br J Surg (1999) 0.98